• Product NameCytochrome P450 2A13 Antibody
• Host SpeciesRabbit
• ClonalityPolyclonal
• PurificationThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
• ApplicationsWB
• Species ReactivityHu
• SpecificityThe antibody detects endogenous levels of total Cytochrome P450 2A13 protein.
• Immunogen TypePeptide
• Immunogen DescriptionSynthesized peptide derived from internal of human Cytochrome P450 2A13.
• Target NameCytochrome P450 2A13
• Alternative Names    Cytochrome P450 2A13; EC 1.14.14.1; CYPIIA13; CP2AD;
• Accession No. Swiss-Prot: Q16696
  NCBI Gene ID: 1553
• UniprotQ16696
• Gene ID1553;
• SDS-PAGE MW 56kd
• Concentration 1.0mg/ml
• Formulation Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
• Storage Store at -20˚C

• Western blotting: 1:500~1:3000
  
  

Exhibits a coumarin 7-hydroxylase activity. Active in the metabolic activation of hexamethylphosphoramide, N,N-dimethylaniline, 2'-methoxyacetophenone, N-nitrosomethylphenylamine, and the tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Possesses phenacetin O-deethylation activity.

Fernandez-Salguero P., Am. J. Hum. Genet. 57:651-660(1995).
Su T., cer Res. 60:5074-5079(2000).
Cauffiez C., m. Biophys. Res. Commun. 317:662-669(2004).

• Western blot analysis of extracts from HeLa cells, 293 cells and A549 cells, using Cytochrome P450 2A13 antibody #34233.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting